Abstract:Background: Pericytes are crucial for the development, stabilization, and functional regulation of microvasculature, especially in the retina. In diabetic retinopathy (DR), early loss of pericytes is a key event that drives microvascular dysfunction. Despite their critical role, the mechanisms underlying the functional heterogeneity of pericytes in DR remain poorly understood, impeding the development of effective therapeutic strategies. Methods: We employed single-cell RNA sequencing to construct a comprehensive single-cell atlas of non-diabetic and diabetic retinas. Using bioinformatic clustering and subcluster analysis, we identified a specific pericyte subcluster associated with diabetic microvascular complications. Differential gene expression analysis and immunofluorescence validation highlighted PTTG1 as a potential key regulator of pericyte dysfunction. To investigate its functional role, we emplyed CRISPR/Cas9 and adenoviral vectors to modulate PTTG1 expression in vitro and in vivo. Combined transcriptomic and metabolomic approaches were used to explore the mechanistic pathways through which PTTG1 influences pericyte biology and vascular function. Results: We identified a novel pericyte subcluster characterized by elevated expression of PTTG1, which was strongly correlated with diabetic microvascular dysfunction. Silencing PTTG1 using CRISPR/Cas9 and siRNA in vitro mitigated pericyte dysfunction under high-glucose conditions. Targeted knockdown of PTTG1 using viral vectors improved retinal vascular integrity and reduced neovascularization in diabetic mice. Transcriptomic and untargeted metabolomic analyses revealed that PTTG1 knockdown reprogrammed pericyte energy metabolism by modulating glycolysis pathway genes, reducing oxidative stress, and restoring pericyte function, ultimately alleviating microvascular dysfunction in DR. Conclusions: PTTG1 plays a critical role in regulating pericyte dysfunction and maintaining vascular homeostasis in diabetic retinopathy. By modulating key metabolic pathways and pericyte phenotypes, PTTG1 represents a promising therapeutic target for treating diabetic microvascular complications. These insights offer a novel molecular framework for developing targeted therapies aimed at restoring retinal vascular health in diabetic patients.

Targeting the PINK1/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathy

PINK1 ‐mitophagy activator ( PA ‐01) overcomes mitochondrial hyperfusion conferring retinal neuroprotection in type‐1 diabetes

The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease

PINK1/Parkin Mediated Mitophagy Ameliorates Palmitic Acid-Induced Apoptosis Through Reducing Mitochondrial ROS Production in Podocytes.

Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1/Parkin-Mediated Mitophagy in Diabetic Retinopathy

Autophagy: A Novel Pharmacological Target in Diabetic Retinopathy

Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy

Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Diabetic Retinopathy: An Attractive but Elusive Choice for Drug Development

Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease

Non-Apoptotic Programmed Cell Death as Targets for Diabetic Retinal Neurodegeneration

Inhibition of Drp1 ameliorates diabetic retinopathy by regulating mitochondrial homeostasis

Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy

PTTG1-Mediated Pericyte Dysfunction Drives Diabetes-Induced Microvascular Dysfunction

Targeting pericyte retention in Diabetic Retinopathy: a review

Promoting mitochondrial dynamics by inhibiting the PINK1/PRKN pathway to relieve diabetic nephropathy

Notoginsenoside R1 Ameliorates Diabetic Retinopathy Through PINK1-Dependent Activation of Mitophagy

Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy

Role of PTEN-Induced Protein Kinase 1 as a Mitochondrial Dysfunction Regulator in Cardiovascular Disease Pathogenesis

PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

Identification and Validation of Mitophagy-Related Genes in Diabetic Retinopathy